Pharmacological Properties of KRN2391, a novel vasodilator of the nitrate-potassium channel opener hybrid type
- 31 July 1994
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 25 (4), 609-616
- https://doi.org/10.1016/0306-3623(94)90235-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Mechanism of Action of KRN2391 in Canine Coronary Vascular BedThe Japanese Journal of Pharmacology, 1993
- Clinical Relevance of Tolerance to NitrovasodilatorsJournal of Cardiovascular Pharmacology, 1991
- Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary DeathJournal of Cardiovascular Pharmacology, 1990
- Effect of KRN2391, a novel vasodilator, on responses induced by several vasoconstrictors in isolated canine coronary arteriesThe Japanese Journal of Pharmacology, 1990
- Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary arteryEuropean Journal of Pharmacology, 1989
- Is the Cardiovascular Profile of BRL 34915 Characteristic of Potassium Channel Activators?Journal of Cardiovascular Pharmacology, 1988
- Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activatorBiochemical Pharmacology, 1987
- Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitriteCanadian Journal of Physiology and Pharmacology, 1981
- Subepicardial vasodilator reserve in the presence of critical coronary stenosis in dogsThe American Journal of Cardiology, 1980
- Coronary steal: Its role in detrimental effect of isoproterenol after acute coronary occlusion in dogsThe American Journal of Cardiology, 1976